ScholarIQanswers from OpenAlex & ORCID
David Gordon
ResearcherPublications, citations & collaboration network
David Gordon is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David Gordon have?
ScholarIQindexed works
David Gordon has 670 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David Gordon have?
ScholarIQcitation count
David Gordon has 44,276 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David Gordon?
ScholarIQh-index
David Gordon has an h-index of 76 in OpenAlex.
What is the i10-index of David Gordon?
ScholarIQi10-index
David Gordon has an i10-index of 305 in OpenAlex.
What is the ORCID of David Gordon?
ScholarIQorcid
The ORCID for David Gordon is on the source record.
What is the OpenAlex record for David Gordon?
ScholarIQopenalex
The OpenAlex for David Gordon is on the source record.
What are the most-cited papers on David Gordon?
ScholarIQmost cited works
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein, C. Noel Bairey Merz, Conrad B. Blum, Robert H. Eckel, Anne C. Goldberg, David Gordon, Daniel Levy, Donald M. Lloyd‐Jones, Patrick E. McBride, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith, Karol E. Watson, Peter W.F. Wilson
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein, C. Noel Bairey Merz, Conrad B. Blum, Robert H. Eckel, Anne C. Goldberg, David Gordon, Daniel Levy, Donald M. Lloyd‐Jones, Patrick E. McBride, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith, Karol E. Watson, Peter W.F. Wilson
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jane Armitage, Colin Baigent, Elizabeth H Barnes, D. J. Betteridge, Lisa Blackwell, Michael A. Blazing, Louise Bowman, Eugene Braunwald, Robert Byington, Christopher P. Cannon, Michael Clearfield, Helen M. Colhoun, Rory Collins, Björn Dahlöf, Kelly Davies, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Jonathan Emberson, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, Jordan Fulcher, John A. Fuller, Curt D. Furberg, David Gordon, Shinya Goto, Antonio M. Gotto, Heather Halls, Charlie Harper, C. Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study
William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E. Hammer, C. Kleoudis, James Groark, Damon Bass, Norma Lynn Fox, David A. Roth, David Gordon
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
Fengchun Zhang, Sang‐Cheol Bae, Damon Bass, Myron Chu, Sally Egginton, David Gordon, David A. Roth, Jie Zheng, Yoshiya Tanaka